1.
Hematol Oncol
; 37(2): 136-142, 2019 Apr.
Article
in English
| MEDLINE
| ID: mdl-30589950
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Doxorubicin/adverse effects , Lymphoma, Large B-Cell, Diffuse/drug therapy , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Drug Substitution , Epirubicin/administration & dosage , Epirubicin/adverse effects , Etoposide/administration & dosage , Etoposide/adverse effects , Female , Follow-Up Studies , Heart Diseases/chemically induced , Heart Diseases/prevention & control , Humans , Kaplan-Meier Estimate , Male , Matched-Pair Analysis , Prednisone/administration & dosage , Progression-Free Survival , Retrospective Studies , Rituximab/administration & dosage , Vincristine/administration & dosage
2.
Acta Oncol
; 57(9): 1265-1267, 2018 09.
Article
in English
| MEDLINE
| ID: mdl-29537344